WASHINGTON, DC-Children afflicted with a rare genetic disease may be helped with a new artificial skin.
The Food and Drug Administration (FDA) recently approved the skin. Children who have epidermolysis bullosa have severe blisters that can scar and leave the fingers melded together like a mitten. Their fingers must be separated surgically, wrapped in non-sticky bandages and healed with skin grafts. The healing process takes extensive amounts of time, leaving the door open for infection.
New York-based Ortec International Inc., wants to change this process with a composite cultured skin made from living skin cells and the foreskins from circumcised newborn baby boys. The new artificial skin is aimed at those who are severely affected by the disease. There are 4,000 people diagnosed per year with EB.
Australian surgeons using the new skin found it helped speed up the healing process, therefore, preventing infection.
Information from www.washingtonpost.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.